She’s one in 200,000. In February 2024, when she was five, Liliana was diagnosed with Morquio syndrome — also known as mucopolysaccharidosis type IV — a rare genetic condition that prevents the body ...

Cushing syndrome occurs due to abnormally high levels of cortisol, which is commonly related to steroid use. Symptoms include weight gain, thinning skin, fluid retention, and stretch marks ...

Enzymes are molecular machines that carry out the chemical reactions that sustain all life, an ability that has captured the attention of scientists like me. Consider muscle movement. Your body ...

What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

Enzymes catalyze nearly all of the chemical ... and holo- states and its interaction with the autoimmune polyendocrine syndrome type 2-associated autoantibody b96.11. Here, the authors develop ...

If you see inaccuracies in our content, please report the mistake via this form. Drawing with a tablet has many benefits, such as portability, chargeability, and limitless visual effects.

Klinefelter syndrome is a genetic condition that affects only males. Here's what you should know about the causes, symptoms, and treatment options for the condition. Klinefelter syndrome is a genetic ...

On January 6th, 2021, X [1] user @pukicho posted a drawing parodying a horror movie trope of children making disturbing drawings that depict a malevolent presence haunting them or their families. The ...

The enzyme replacement therapy (ERT) market is projected to grow significantly, rising from US$ 10,707.6 million in 2024 to US$ 20,289.1 million by 2034, at a robust CAGR of 6.60% over the forecast ...

Chronic fatigue syndrome — also known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) OR systemic exertional intolerance disease (SEID)— is a serious, chronic illness that can ...

BioMarin's roots are in enzyme replacement therapies for ultra ... and no alternative drug therapies exist. Vimizim in Morquio A syndrome and Brineura in CLN2 disease should also drive growth.